VERACYTE, INC. Contracts & Agreements

2023 Equity Incentive Plan, as Amended (Filed With SEC on June 13, 2024)

Form of Stock Option Assumption Notice by the Registrant to Option holders of C2i Genomics, Inc (Filed With SEC on February 29, 2024)

Form of Option Grant under the 2019 Stock Incentive Plan of C2i Genomics, Inc (Filed With SEC on February 29, 2024)

Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on February 29, 2024)

Promotion Letter, dated as of (Filed With SEC on February 29, 2024)

Change of Control and Severance Agreement, effective September 1, 2023, between John Leite and the Registrant (Filed With SEC on February 29, 2024)

Offer Letter, dated as of (Filed With SEC on February 29, 2024)

Change of Control and Severance Agreement, effective (Filed With SEC on February 29, 2024)

2019 Stock Incentive Plan of C2i Genomics, Inc (Filed With SEC on February 29, 2024)

Advisor Agreement, effective September 4, 2023, by and between Tina S. Nova and the Registrant (Filed With SEC on November 8, 2023)

Form of agreements under the 2023 Equity Incentive Plan (Filed With SEC on June 9, 2023)

Change of Control and Severance Agreement, effective January 1, 2023, between Annie McGuire and the Registrant (Filed With SEC on March 1, 2023)

Offer Letter, dated as of January 9, 2023, between Annie McGuire and the Registrant (Filed With SEC on March 1, 2023)

Separation Agreement dated December 13, 2022 between Giulia Kennedy and the Registrant (Filed With SEC on March 1, 2023)

Transition and Separation Agreement, effective February 21, 2022, between Beverly Jane Alley and the Registrant (Filed With SEC on May 4, 2022)

Change of Control and Severance Agreement, effective February 28, 2022, between Annie McGuire and the Registrant (Filed With SEC on May 4, 2022)

Offer Letter, dated as of February 7, 2022, between Annie McGuire and the Registrant (Filed With SEC on May 4, 2022)

Change of Control and Severance Agreement, effective February 2, 2021, between Tina S. Nova and the Registrant (Filed With SEC on May 4, 2022)

Offer Letter, dated as of February 2, 2021, between Tina S. Nova and the Registrant (Filed With SEC on May 4, 2022)

Amended and Restated Employment Agreement, dated as of April 20, 2022, between Bonnie Anderson and the Registrant (Filed With SEC on May 4, 2022)

Amended and Restated Offer Letter, dated August 15, 2021, between the Registrant and Rebecca Chambers (Filed With SEC on November 9, 2021)

Change in Control and Severance Agreement, effective July 19, 2021 between Rebecca Chambers and the Registrant (Filed With SEC on November 9, 2021)

Employment Agreement, dated as of May 28, 2021, between Bonnie Anderson and the Registrant (Filed With SEC on July 29, 2021)

Employment Agreement, dated as of May 7, 2021, between Marc Stapley and the Registrant (Filed With SEC on July 29, 2021)

Change in Control and Severance Agreement, effective June 1, 2021 between Marc Stapley and the Registrant (Filed With SEC on July 29, 2021)

Memorandum of Understanding between the Shareholders of HalioDx and the Registrant (Filed With SEC on July 29, 2021)

Securities Purchase and Contribution Agreement between the Shareholders of HalioDx and the Registrant (Filed With SEC on July 29, 2021)

Agreement and Plan of Merger between Decipher Biosciences, Inc., the Registrant, and the parties thereto, dated as of February 2, 2021 (Filed With SEC on May 10, 2021)

2013 Stock Incentive Plan, as amended (Filed With SEC on March 3, 2021)

Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on February 22, 2021)

Amended and Restated Change in Control and Severance Agreement, effective (Filed With SEC on February 22, 2021)

Offer Letter dated as of (Filed With SEC on February 22, 2021)

Underwriting Agreement dated February 4, 2021 (Filed With SEC on February 5, 2021)

Form of stock unit award agreement (Filed With SEC on November 2, 2020)

Form of stock option award agreement (Filed With SEC on November 2, 2020)

Underwriting Agreement dated August 4, 2020 (Filed With SEC on August 5, 2020)

Enrollment Form for the Amended and Restated Employee Stock Purchase Plan (Filed With SEC on July 30, 2020)

Amended and Restated Employee Stock Purchase Plan (Filed With SEC on June 9, 2020)

Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on February 25, 2020)

Offer Letter dated as of August 9, 2011 with John Hanna (Filed With SEC on February 25, 2020)

Offer Letter dated as of March 5, 2008 with Giulia Kennedy (Filed With SEC on February 25, 2020)

License and Asset Purchase Agreement, dated December 3, 2019, by and among Veracyte, Inc. and NanoString, Inc (Filed With SEC on December 3, 2019)

Registration Rights Schedule, dated December 3, 2019 (Filed With SEC on December 3, 2019)

Amended and Restated Change of Control and Severance Agreement, effective July 1, 2019 between John Hanna and the Registrant (Filed With SEC on July 30, 2019)

Amended and Restated Change of Control and Severance Agreement, effective July 1, 2019 between Giulia Kennedy and the Registrant (Filed With SEC on July 30, 2019)

Amended and Restated Change of Control and Severance Agreement, effective July 1, 2019 between Keith Kennedy and the Registrant (Filed With SEC on July 30, 2019)

Amended and Restated Change of Control and Severance Agreement, effective July 1, 2019 between Bonnie Anderson and the Registrant (Filed With SEC on July 30, 2019)

Services and Separation Agreement, effective April 22, 2019 between Chris Hall and the Registrant (Filed With SEC on July 30, 2019)

Underwriting Agreement dated May 2, 2019 (Filed With SEC on May 3, 2019)

Agreement dated as of October 16, 2017, between Thyroid Cytopathology Partners, P.A. and the Registrant, as amended (Filed With SEC on April 30, 2019)

Amended and Restated Change in Control and Severance Agreement, effective October 23, 2018 between Keith Kennedy and the Registrant (Filed With SEC on February 25, 2019)

Amended and Restated Change in Control and Severance Agreement, effective October 23, 2018 between Bonnie Anderson and the Registrant (Filed With SEC on February 25, 2019)

Amended and Restated Change in Control and Severance Agreement, effective October 23, 2018 between Christopher Hall and the Registrant (Filed With SEC on February 25, 2019)

Diagnostic Development Agreement, dated December 28, 2018, between Johnson & Johnson Services, Inc. and the Registrant (Filed With SEC on February 25, 2019)

Underwriting Agreement dated July 25, 2018 (Filed With SEC on July 26, 2018)

Form of Performance Stock Unit (Filed With SEC on May 1, 2018)

2013 Stock Incentive Plan, as amended, and forms of stock option award agreement, stock option exercise agreement, restricted stock agreement and restricted stock unit agreement (Filed With SEC on February 27, 2018)

First Amendment to Office Building Lease dated May 3, 2016 by and between American Fund US Investments LP and the Registrant (Filed With SEC on February 27, 2018)

Amended and Restated Pathology Services Agreement dated as of October 16, 2017 between Thyroid Cytopathology Partners, P.A. and the Registrant (Filed With SEC on February 27, 2018)

Loan and Security Agreement dated as of November 3, 2017 between Silicon Valley Bank and the Registrant (Filed With SEC on February 27, 2018)

Offer Letter dated as of November 17, 2016 with Keith Kennedy (Filed With SEC on February 27, 2018)

Second Amendment to Lease Agreement dated August 14, 2017 between the Company and BRI 1868 Riata, LLC (Filed With SEC on November 7, 2017)

VERACYTE, INC. 2013 STOCK INCENTIVE PLAN (Adopted by the Board of Directors on October 2, 2013) (As amended by the Board of Directors on May 23, 2017) (Filed With SEC on July 31, 2017)

VERACYTE,INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on March 1, 2017)

FIRST AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on March 1, 2017)

VERACYTE, INC. 2013 STOCK INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on March 1, 2017)

SECOND AMENDMENT TO LEASE (Filed With SEC on March 1, 2017)

VERACYTE, INC. (a Delaware corporation) 5,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 2, 2016)

CONSENT AND SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 24, 2015)

VERACYTE, INC. EMPLOYEE STOCK PURCHASE PLAN (as adopted March 10, 2015 by the Board and approved May 18, 2015 by the shareholders) (Filed With SEC on August 13, 2015)

OFFICE BUILDING LEASE BY AND BETWEEN AMERICAN FUND US INVESTMENTS LP, a Delaware limited partnership LANDLORD AND VERACYTE, INC., A Delaware corporation TENANT DATED April 29,... (Filed With SEC on August 13, 2015)

VERACYTE, INC. AMENDED AND RESTATED CHANGE OF CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on May 15, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 24, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 24, 2015)

EX-U.S. CO-PROMOTION AGREEMENT (Filed With SEC on March 25, 2015)

CONSENT AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 18, 2014)

AMENDED AND RESTATED U.S. CO-PROMOTION AGREEMENT (Filed With SEC on November 13, 2014)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on November 13, 2014)

Letter of Agreement for Proposed Second Amendment to Co-Promotion Agreement (Filed With SEC on August 14, 2014)

SECOND AMENDMENT TO PATHOLOGY SERVICES AGREEMENT (Filed With SEC on March 20, 2014)

FIRST AMENDMENT TO LEASE AGREEMENT (Filed With SEC on March 20, 2014)

Shares VERACYTE, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on October 25, 2013)

Shares VERACYTE, INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on October 17, 2013)

VERACYTE, INC. 2013 STOCK INCENTIVE PLAN (Adopted by the Board of Directors on October 2, 2013) (Filed With SEC on October 7, 2013)

INDEMNIFICATION AGREEMENT (Filed With SEC on October 7, 2013)

WARRANT TO PURCHASE STOCK (Filed With SEC on September 20, 2013)

VERACYTE, INC. 2008 STOCK PLAN (Amended July 15, 2009) (Filed With SEC on September 20, 2013)

VERACYTE, INC. AMENDMENT TO SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on September 20, 2013)

VERACYTE, INC. SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT November 6, 2012 (Filed With SEC on September 20, 2013)

Category

Industry

Companies

Contracts

VERACYTE, INC. Contracts & Agreements